Frankfurt, Germany

Frank Ricther

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Ricther - Innovator in Drug Delivery Technology

Introduction

Frank Ricther is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of drug delivery technology. His innovative approach has led to the development of a unique drug delivery device that enhances the efficiency of medication administration.

Latest Patents

Frank Ricther holds a patent for a drug delivery device. This invention comprises a syringe with a body from which a needle extends and an inner sheath. It also includes a piston rod featuring a piston and an actuation head, along with a support sheath for holding the body. The design envisions that the support sheath and the actuation head comprise corresponding indicators, which improve usability and precision in drug delivery.

Career Highlights

Frank Ricther is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry. With a strong background in engineering and medicine, he has been able to bridge the gap between technology and healthcare.

Collaborations

Some of his notable coworkers include Stefan Wendland and Anke Liewald. Their collaborative efforts have contributed to advancements in drug delivery systems and have fostered a culture of innovation within their team.

Conclusion

Frank Ricther's contributions to drug delivery technology exemplify the impact of innovation in healthcare. His patent for a drug delivery device showcases his commitment to improving patient care through advanced technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…